| | | |

Mesothelioma-Related Weight Loss: Synthetic Cannabinoid Might Help

ByAlex Strauss

mesothelioma-related weight loss

The first patient has been treated in the trial of a new drug that might help people suffering from mesothelioma-related weight loss.

The drug is a synthetic cannabinoid called ART27.13. A cannabinoid is a compound that acts on the CB1 and CB2 receptors of the endocannabinoid system. There are a number of cannabinoid drugs on the market. But several of them have significant side effects, including effects on the brain. 

Preclinical data on ART27.13 suggest that it may stimulate the appetite and counter mesothelioma-related weight loss with fewer unwanted side effects. The Cancer Appetite Recovery Study (CAReS) is a Phase I trial to test it in people.

The Danger of Mesothelioma-Related Weight Loss

Over 60 percent of late-stage cancer patients lose their appetites. This is also called anorexia. People with mesothelioma may not feel like eating. Mesothelioma treatments like chemotherapy and radiation can make patients feel sick, leading to further weight loss.

Mesothelioma-related weight loss can be serious. Anorexic patients may become weak and dehydrated. The problem can weaken the immune system and hurt patients’ quality of life. Cancer patients who are severely underweight face a worse prognosis.

The American Society of Clinical Oncology guidelines contain no standard of care for mesothelioma-related weight loss. There are some drugs that doctors can use off-label to treat the problem. One of these is another cannabinoid called Dronabinol. 

But most of the existing drugs used for cancer-related anorexia are not very effective. Several also cause unwanted side effects. Early data suggests that ART27.13 is different. 

“So many patients have suffered with substandard options to address the profound weight loss from cancer,” writes lead investigator Barry J.A. Laird, MD, of Scotland’s University of Edinburgh. “With ART27.13 there are grounds for optimism that loss of appetite associated with cancer can be successfully treated.” 

ART27.13 and the Endocannabinoid System

ART27.13 acts on the endocannabinoid system. There are many molecules in nature that can also act on this system and potentially stimulate appetite. 

“However, these molecules are not optimized,” Artelo Biosciences scientific advisor Saoirse O’Sullivan explained in an interview with Outsourcing-Pharma. “Many are very insoluble and poorly absorbed in the body. Some are not very potent. Many are found in tiny quantities in nature.”

Synthetic cannabinoids can be manipulated to increase their impact while decreasing their side effects. This may enhance their ability to fight mesothelioma-related weight loss.

ART27.13 was originally in development by AstraZeneca as a pain reliever. They called it AZD1940. It was not as effective as the company had hoped so they abandoned the project. 

But scientists at Artelo Biosciences noticed that the drug caused rapid weight gain in the original test subjects. These patients had no other serious or ongoing side effects. If it works, ART27.13 could be a breakthrough for people with mesothelioma-related weight loss.

“Notably, we anticipate that we will be able to collect initial safety data from Phase 1 of CAReS before the end of this year, which will determine the most effective and safest dose of ART27.13 to utilize in Phase 2 of the study,” says Andrew Yates, PhD, Senior Vice President and Chief Scientific Officer of Artelo.

Source:

“Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss”, April 12, 2021, News Release, Artelo Biosciences website, https://ir.artelobio.com/news-events/press-releases/detail/60/artelo-biosciences-doses-first-patient-in-cares-study-with

Spinner, Jenni, “Study explores synthetic cannabinoid for cancer-related anorexia”, April 20, 2021, https://www.outsourcing-pharma.com/Article/2021/04/20/Study-explores-synthetic-cannabinoid-for-cancer-anorexia?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright

 

 

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    ByAlex Strauss

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…